Cargando…

Activity of the Bacillus anthracis 20 kDa protective antigen component

BACKGROUND: Anthrax is caused by Bacillus anthracis that produce two exotoxins, lethal toxin and edema toxin. The lethal toxin is composed of the lethal factor (LF) complexed with the cell binding protective antigen (PA(83), 83 kDa). Likewise, the edema factor (EF) binds to the PA(83 )to form the ed...

Descripción completa

Detalles Bibliográficos
Autores principales: Hammamieh, Rasha, Ribot, Wilson J, Abshire, Terry G, Jett, Marti, Ezzell, John
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2564935/
https://www.ncbi.nlm.nih.gov/pubmed/18808698
http://dx.doi.org/10.1186/1471-2334-8-124
_version_ 1782159815846395904
author Hammamieh, Rasha
Ribot, Wilson J
Abshire, Terry G
Jett, Marti
Ezzell, John
author_facet Hammamieh, Rasha
Ribot, Wilson J
Abshire, Terry G
Jett, Marti
Ezzell, John
author_sort Hammamieh, Rasha
collection PubMed
description BACKGROUND: Anthrax is caused by Bacillus anthracis that produce two exotoxins, lethal toxin and edema toxin. The lethal toxin is composed of the lethal factor (LF) complexed with the cell binding protective antigen (PA(83), 83 kDa). Likewise, the edema factor (EF) binds to the PA(83 )to form the edema toxin. Once PA83 is bound to the host cell surface, a furin-like protease cleaves the full-length, inactive protein into 63 kDa and 20 kDa antigens (PA(63 )and PA(20)). PA(63 )forms a heptamer and is internalized via receptor mediated endocytosis forming a protease-stable pore, which allows EF and LF to enter the cell and exert their toxic effects. Both proteolytically cleaved protective antigens (PA(63 )and PA(20 )fragments) are found in the blood of infected animals. The 63 kDa protective antigen PA(63 )fragment has been thoroughly studied while little is known about the PA(20). METHODS: In this study we examined the role of PA(20 )using high throughput gene expression analysis of human peripheral blood mononuclear cells (PBMC) exposed to the PA(20). We constructed a PA mutant in which a Factor Xa proteolytic recognition site was genetically engineered into the protective antigen PA(83 )to obtain PA(20 )using limited digestion of this recombinant PA(83 )with trypsin. RESULTS: Global gene expression response studies indicated modulation of various immune functions and showed gene patterns indicative of apoptosis via the Fas pathway in a subset of the lymphoid cells. This finding was extended to include observations of increased Caspase-3 enzymatic activity and the identification of increases in the population of apoptotic, but not necrotic cells, based on differential staining methods. We identified a list of ~40 inflammatory mediators and heat-shock proteins that were altered similarly upon exposure of PBMC to either rPA(20 )or B. anthracis spores/vegetative cells. CONCLUSION: This study shows that the PA(20 )has an effect on human peripheral blood leukocytes and can induce apoptosis in the absence of other PA components.
format Text
id pubmed-2564935
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-25649352008-10-09 Activity of the Bacillus anthracis 20 kDa protective antigen component Hammamieh, Rasha Ribot, Wilson J Abshire, Terry G Jett, Marti Ezzell, John BMC Infect Dis Research Article BACKGROUND: Anthrax is caused by Bacillus anthracis that produce two exotoxins, lethal toxin and edema toxin. The lethal toxin is composed of the lethal factor (LF) complexed with the cell binding protective antigen (PA(83), 83 kDa). Likewise, the edema factor (EF) binds to the PA(83 )to form the edema toxin. Once PA83 is bound to the host cell surface, a furin-like protease cleaves the full-length, inactive protein into 63 kDa and 20 kDa antigens (PA(63 )and PA(20)). PA(63 )forms a heptamer and is internalized via receptor mediated endocytosis forming a protease-stable pore, which allows EF and LF to enter the cell and exert their toxic effects. Both proteolytically cleaved protective antigens (PA(63 )and PA(20 )fragments) are found in the blood of infected animals. The 63 kDa protective antigen PA(63 )fragment has been thoroughly studied while little is known about the PA(20). METHODS: In this study we examined the role of PA(20 )using high throughput gene expression analysis of human peripheral blood mononuclear cells (PBMC) exposed to the PA(20). We constructed a PA mutant in which a Factor Xa proteolytic recognition site was genetically engineered into the protective antigen PA(83 )to obtain PA(20 )using limited digestion of this recombinant PA(83 )with trypsin. RESULTS: Global gene expression response studies indicated modulation of various immune functions and showed gene patterns indicative of apoptosis via the Fas pathway in a subset of the lymphoid cells. This finding was extended to include observations of increased Caspase-3 enzymatic activity and the identification of increases in the population of apoptotic, but not necrotic cells, based on differential staining methods. We identified a list of ~40 inflammatory mediators and heat-shock proteins that were altered similarly upon exposure of PBMC to either rPA(20 )or B. anthracis spores/vegetative cells. CONCLUSION: This study shows that the PA(20 )has an effect on human peripheral blood leukocytes and can induce apoptosis in the absence of other PA components. BioMed Central 2008-09-22 /pmc/articles/PMC2564935/ /pubmed/18808698 http://dx.doi.org/10.1186/1471-2334-8-124 Text en Copyright © 2008 Hammamieh et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Hammamieh, Rasha
Ribot, Wilson J
Abshire, Terry G
Jett, Marti
Ezzell, John
Activity of the Bacillus anthracis 20 kDa protective antigen component
title Activity of the Bacillus anthracis 20 kDa protective antigen component
title_full Activity of the Bacillus anthracis 20 kDa protective antigen component
title_fullStr Activity of the Bacillus anthracis 20 kDa protective antigen component
title_full_unstemmed Activity of the Bacillus anthracis 20 kDa protective antigen component
title_short Activity of the Bacillus anthracis 20 kDa protective antigen component
title_sort activity of the bacillus anthracis 20 kda protective antigen component
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2564935/
https://www.ncbi.nlm.nih.gov/pubmed/18808698
http://dx.doi.org/10.1186/1471-2334-8-124
work_keys_str_mv AT hammamiehrasha activityofthebacillusanthracis20kdaprotectiveantigencomponent
AT ribotwilsonj activityofthebacillusanthracis20kdaprotectiveantigencomponent
AT abshireterryg activityofthebacillusanthracis20kdaprotectiveantigencomponent
AT jettmarti activityofthebacillusanthracis20kdaprotectiveantigencomponent
AT ezzelljohn activityofthebacillusanthracis20kdaprotectiveantigencomponent